Login to Your Account



Pharma: Clinic Roundup


Tuesday, June 18, 2013
• Ipsen SA, of Paris, relased results of an international Phase IIIB study, PRIMARYS, assessing an investigational use of Somatuline Autogel (lanreotide) 120 mg as first-line therapy in newly diagnosed acromegaly patients with a macroadenoma.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription